Search Results - Idink, Cecile

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

    Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL by van der Straten, Lina, Stege, Claudia A. M., Kersting, Sabina, Nasserinejad, Kazem, Dubois, Julie, Dobber, Johan A., Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie F., Evers, Ludo M., de Boer, Fransien, Koene, Harry R., Schreurs, John, van der Klift, Marjolein, Velders, Gerjo A., van der Spek, Ellen, van der Straaten, Hanneke M., Hoogendoorn, Mels, van Gelder, Michel, Posthuma, Eduardus F. M., Visser, Hein P. J., Houtenbos, Ilse, Idink, Cecile A. M., Issa, Djamila E., Dompeling, Ellen C., van Zaanen, Henk C. T., Veelken, J. Hendrik, Levenga, Henriette, Tick, Lidwine W., Terpstra, Wim E., Tonino, Sanne H., Westerweel, Peter E., Langerak, Anton W., Kater, Arnon P., Levin, Mark-David, Beckers, M. M. J., Bekker, A., Bellido, M., de Boer, F., Broers, R., Chamuleau, M., Croockewit, A. J., Dompeling, E. C., Eefting, M., van Gelder, M., Hoogendoorn, M., Houtenbos, I., Doorduijn, J. K., Droogendijk, J., van der Griend, R., de Heer, K., Henkens, C. M. A., Idink, C. A. M., Issa, D. E., van Kampen, R., Kater, A. P., Kersting, S., van der Klift, M., Laterveer, L., Levenga, H., Levin, M-D., Mous, R., Nijland, M., Nijziel, M., van Norden, Y., Posthuma, E. F. M., te Raa, G. D., Raymakers, R. A. P., Regelink, J. C., Sandberg, Y., Schaafsma, M. R., Silbermann, M. H., van der Spek, A. C., van der Straaten, H. M., Tanis, B., Terpstra, W. E., Tick, L. W., Tonino, S. H., Veelken, J. H., Velders, G. A., Vlasveld, L., Visser, H. P. J., Vos, J. M. I., Wittebol, S., van Zaanen, H. C. T.

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB‐VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL

    P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB‐VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON... by Kersting, Sabina, Levin, Mark‐David, Dubois, Julie, Norden, Yvette, Dobber, Johan, Jauw, Yvonne, Kevie‐Kersemaekers, Anne‐Marie, Mellink, Clemens, Da Cunha‐Bang, Caspar, Van Desr Burg, Leonie, Te Raa, Doreen, Boer, Fransien, Droogendijk, Jolanda, Idink, Cecile, De Heer, Koen, Nijziel, Marten, Tick, Lidwine, Ludwig, Inge, Silbermann, Mathijs, Beeker, Aart, Bellido, Mar, Evers, Ludo, Zwezerijnen, Gerben, Zijlstra, Josée, Kap, Marcel, Niemann, Carsten, Kater, Arnon

    Published in HemaSphere
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the Phase 2 HOVON 158/Next STEP Trial

    Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the... by Levin, Mark-David, Kersting, Sabina, Dubois, Julie M.N., Norden, Yvette, Dobber, Johan A, Jauw, Yvonne W.S., Kevie-Kersemaekers, Anne-Marie van der, Mellink, Clemens, Heer, Koen de, Burg, Leonie van der, Raa, Doreen Te, Boer, Fransien de, Droogendijk, Jolanda, Idink, Cecile, Nijziel, Marten R., Tick, Lidwine W., Ludwig, Inge, Silbermann, Matthijs, Beeker, Aart, Bellido, Mar, Evers, Ludo M., Zwezerijnen, Gerben JC, Niemann, Carsten U, Kater, Arnon P.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia

    The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia by Visser, Chantal, Swinkels, Maurice, van Werkhoven, Erik D., Croles, F. Nanne, Noordzij, Heike, Eefting, Matthijs, Last-Koopmans, Suzanne M., Idink, Cecile, Westerweel, Peter E., Santbergen, Bart, Jobse, Pieter A., Baboe, Fazil, Consortium, Recovac-IR, Levin, Mark-David, Kruip, Marieke J.H.A., Jansen, A.J. Gerard

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    COVID-19 vaccination in patients with immune thrombocytopenia

    COVID-19 vaccination in patients with immune thrombocytopenia by Visser, Chantal, Swinkels, Maurice, van Werkhoven, Erik D., Croles, F. Nanne, Noordzij-Nooteboom, Heike S., Eefting, Matthijs, Last-Koopmans, Suzanne M., Idink, Cecile, Westerweel, Peter E., Santbergen, Bart, Jobse, Pieter A., Baboe, Fazil, te Boekhorst, Peter A.W., Leebeek, Frank W.G., Levin, Mark-David, Kruip, Marieke J.H.A., Jansen, A.J. Gerard

    Published in Blood advances
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL

    Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL by Kater, Arnon P., Kersting, Sabina, van Norden, Yvette, Dubois, Julie, Dobber, Johan A., Mellink, Clemens H., Evers, Ludo M., Croon-de Boer, Fransien, Schreurs, John, van der Spek, Ellen, Visser, Hein, Idink, Cecile, Wittebol, Shulamiet, Hoogendoorn, Mels, Tonino, Sanne H., Mobasher, Mehrdad, Levin, Mark-David

    Published in Blood advances
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: